Indian Generics Maker Settles with Plaintiffs in U.S. Price-Fixing Case

Two U.S. subsidiaries of Indian generics company Sun Pharmaceutical Industries have reached settlements totaling $85 million with plaintiffs in the companies’ drug-pricing antitrust litigation, said Sun in a statement.
Source: Drug Industry Daily